Skip to content
Get alerts
GovInfoNow
Unrated Drug recall · FDA · Published August 21, 2026

Broadway Joe's Pain Cream Recall: Potential Contamination Risk

Broadway Joe's recalls 3000g CBD pain cream due to potential raw material contamination. Affected lots expire January 2027. Consumers should check product labels for lot numbers.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0829-2026DrugBroadway Joe's ›
✎ GovInfoNow plain-language explainer

Broadway Joe's is recalling its 3000g CBD pain cream because of potential contamination during manufacturing. This could pose a health risk if the product contains harmful substances. Consumers should stop using the product if they have it. Read more at govinfonow.com/recall/838279-broadway-joe-s-pain-cream-recall-potential-contamination-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/838279-broadway-joe-s-pain-cream-recall-potential-contamination-risk · Updated September 16, 2026 · FDA enforcement record: FDA #D-0829-2026

Cite this page

“Broadway Joe's Pain Cream Recall: Potential Contamination Risk.” GovInfoNow, updated September 16, 2026. https://govinfonow.com/recall/838279-broadway-joe-s-pain-cream-recall-potential-contamination-risk. Based on FDA recall #D-0829-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0829-2026%22&limit=1).

Lexia LLC voluntarily recalled Broadway Joe's Pain Cream due to current good manufacturing practice deviations and potential raw material contamination, the FDA said on Aug. 21, 2026.

How to tell if you have it

  • Brand: Broadway Joe's
  • Product: Broadway Joe's Pain Cream, 3000 gm CBD, (Histamine Dihydrochloride 0.025%) (CDB Isolate 3000mg, HempSeed Oil 2000mg),4 oz-jar
  • NDC: 83088-8120-6
  • UPC: 8 50041 64004 4
  • Lot codes: T1110 (Exp: 1/7/2027), T1111 (Exp: 1/9/2027), T1112 (Exp: 1/16/2027), T1113 (Exp: 1/17/2027), T1114 (Exp: 1/17/2027)
  • Quantity: 1,200 units
  • Distribution: Colorado

The hazard

The recall addresses CGMP deviations involving potential contamination of raw material. The FDA classified the recall as Class II.

Context

GovInfoNow's records show other recent recalls include Blaine Labs Revitaderm Gel Recall on 2026-04-08 and Trifluent Pharma Wound Care Gel Recall on 2026-04-08. Wells Pharma Fentanyl Citrate Injectable Solution Recall occurred on 2026-04-01.

How to tell if you have this one

Check the product label for lot numbers T1110 through T1114. The product comes in 4-ounce jars with specific expiration dates (January 2027).

  • Brand
    Broadway Joe's
  • Product
    Broadway Joe's Pain Cream, 3000 gm CBD, (Histamine Dihydrochloride 0.025%) (CDB Isolate 3000mg, HempSeed Oil 2000mg),4
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    Distributed in the state of Colorado (US).
Recall numberProduct, codes & lotsQuantity
D-0828-2026Broadway Joe's Pain Cream, (Histamine Dihydrochloride 0.025%), 1500mg CBD Isolate, 1000mg Hempseed oil, 2 oz-jar, Produced for Broadway Joe's, Franklin, TN, 37067, NDC 83088-8120-5, UPC 8 50041 64003 7; Lot #: T1110, Exp: 1/7/2027; T1111, Exp: 1/9/2027; T1112, Exp: 1/16/2027; T1113, Exp: 1/17/2027; T1114, Exp: 1/17/20272,400 2 oz-jars
D-0829-2026Broadway Joe's Pain Cream, 3000 gm CBD, (Histamine Dihydrochloride 0.025%) (CDB Isolate 3000mg, HempSeed Oil 2000mg),4 oz-jar, Produced for Broadway Joe's, Franklin, TN, 37067, NDC 83088-8120-6; UPC 8 50041 64004 4; Lot #: T1110, Exp: 1/7/2027; T1111, Exp: 1/9/2027; T1112, Exp: 1/16/2027; T1113, Exp: 1/17/2027; T1114, Exp: 1/17/20271,200 4 oz-Jar
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for lot numbers T1110 through T1114 on the product label.

Where it went and when

Where it was distributed

Distributed in Colorado.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: yesCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “Distributed in the state of Colorado (US).” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Colorado.

Recall timeline

FDA published this recall 19 days after the firm started it.

1. Firm started the recall: Aug 21, 202612. FDA classified it Class II: Sep 2, 202623. Published in FDA’s Enforcement Report: Sep 9, 202634. Added to GovInfoNow: Sep 15, 202642026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

Similar recalls

American Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence
American Health PackagingTeva Recalls Metoclopramide Tablets Due to Foreign Contaminants
Teva Pharmaceuticals USA, IncPreferred Pharma Recalls Lidocaine Ointment Due to Content Issues
Preferred Pharmaceuticals, Inc.Northstar Rx Recalls Tretinoin Cream Due to Impurities
SUN PHARMACEUTICAL INDUSTRIES INCApothecary Pharma Recalls Tirzepatide Injections Due to Sterility Risk
Apothecary Pharma LLC

Latest drug recalls

Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx
Cipla USA · September 18, 2026Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma · September 17, 2026Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company recalls Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with
Insight Pharmaceuticals · September 15, 2026K.C. Pharmaceuticals, Inc. recalls Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO
Leader / TopCare / Crocodile Tears · September 11, 2026Amneal Pharmaceuticals, LLC recalls Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater,
Amneal Pharmaceuticals · September 8, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0829-2026 (August 21, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0829-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on September 16, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA